$108.99 Original price was: $108.99.$27.00Current price is: $27.00.
By David Bernstein MD FAASLD FACG FACP AGAF
Obesity has devastating effects on a patient’s overall health, with specific negative effects on organ systems, long-term. The hepatologist must often manage diseases of the liver and pancreas as a result of obesity. This issue will provide a current update on the diagnosis, treatment, and management of NAFLD and NASH. Dr. Bernstein has assembled the top leaders in the field to provide timely clinical reviews.
Clinical and economic burden of NAFLD/NASH
NAFLD/NASH in children and its implications
Natural history of NAFLD/NASH
Diagnosis and evaluation of NAFLD/NASH
Radiological imaging in NAFLD/NASH
The use of liver biopsy in NAFLD: When to biopsy and in whom
Pathophysiology of NAFLD/NASH
Risk factors for the development of NAFLD/NASH including genetics
Role of intestinal microbes in NAFLD/NASH
NAFLD/NASH and the metabolic syndrome
NAFLD/NASH and lipid and insulin resistance
NAFLD/NASH and cardiac disease
Current treatment of NAFLD/NASH
Emerging treatment of NAFLD/NASH
NAFLD/NASH and HCC and NAFLD/NASH and liver transplantation
Readers will have a clear understanding of how to manage outcomes for these patients.
Product Details:
Published by: Elsevier
1st edition (December 19, 2017)
Language: English
ISBN-10: 0323569862
ISBN-13: 978-0323569866
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline